This study assesses the incidence, histogenesis, and significance of eccrine sweat duct involvement in Bowen's disease (BD). In a review of 96 cases of BD, four showed eccrine duct involvement on hematoxylin and eosin-stained histologic sections. One case was analyzed for deoxyribonucleic acid (DNA) ploidy by using computerized image analysis on Feulgen-stained slides. Sections were also stained immunohistochemically, using antibodies to carcinoembryonic antigen (CEA), gross cystic disease fluid protein (GCDFP), and S-100 protein, and for cytokeratins (CAM 5.2, AE 1/3). Our results showed that, in BD, (a) the eccrine sweat ducts can be extensively involved by atypical cells, (b) the atypical eccrine duct cells had an aneuploid DNA pattern, and (c) the atypical eccrine duct cells were negative for CEA, GCDFP, and S-100 protein but were positive for cytokeratins. We conclude that (a) the frequency of eccrine duct involvement in BD is relatively low (approximately 4 to 9%), (b) the aneuploid DNA pattern makes a benign squamous metaplasia unlikely, (c) the immunohistochemical results exclude coincidental Paget's disease or carcinoma of eccrine sweat glands, (d) the involvement of eccrine sweat ducts may represent a direct extension of the neoplastic epidermal keratinocytes, and (e) this process may have practical implications in the recurrence of superficially treated cases of BD.

译文

:本研究评估了鲍文氏病(BD)中内分泌汗管受累的发生率,组织发生和意义。在对96例BD病例的回顾中,有4例显示苏木精和曙红染色的组织切片受累于内分泌管。通过对Feulgen染色载玻片进行计算机图像分析,对一例进行了脱氧核糖核酸(DNA)倍性分析。还使用抗癌胚抗原(CEA),总胆囊疾病液蛋白(GCDFP)和S-100蛋白以及细胞角蛋白(CAM 5.2,AE 1/3)的抗体对切片进行免疫组织化学染色。我们的研究结果表明,在BD中,(a)非典型分泌管可广泛参与非典型分泌管的分泌汗管,(b)非典型分泌管具有非整倍体DNA模式,(c)非典型分泌管对CEA呈阴性,GCDFP和S-100蛋白,但细胞角蛋白呈阳性。我们得出的结论是:(a)BD内分泌管受累的频率相对较低(约4%至9%),(b)非整倍体DNA模式使得良性鳞状化生不太可能,(c)免疫组织化学结果排除了巧合的Paget病或内分泌汗腺癌;(d)内分泌汗管受累可能代表赘生性表皮角质形成细胞的直接延伸;(e)此过程可能对表面治疗的BD病例的复发具有实际意义。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录